Botulinum Toxin and Related Neurological Disorders
Botulinum Toxin and Related Neurological Disorders is a research topic within Neurology. Science Explorer counts 43k research works in it since 1950. 13.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the use of Botulinum Toxin in neurology and medicine, particularly in the treatment of spasticity, stroke-related complications, pain management, and neurological disorders. It covers topics such as the mechanism of action, protein receptors, toxicology, and the clinical application of Botulinum Toxin.
- Botulinum Toxin
- Neurotoxins
- Spasticity
- Stroke
- Neurological Disorders
- Pain Management
- Muscle Mechanics
- Protein Receptor
- Toxicology
- Treatment
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 6k per year above
- Top-10% rate
- 13.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Botulinum Toxin and Related Neurological Disorders research?
By volume, the United States and China publish the most (1.5k and 696 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 696 works
- 3 India 392 works
- 4 Brazil 299 works
- 5 United Kingdom 298 works
- 6 Italy 294 works
- 7 Japan 289 works
- 8 France 275 works
- 9 Germany 263 works
- 10 Türkiye 253 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Botulinum Toxin and Related Neurological Disorders research?
By volume in 2022–2025, Cairo University publishes the most Botulinum Toxin and Related Neurological Disorders research, followed by Yonsei University and Yale University.
By volume, 2022–2025
- 1 Cairo UniversityEgypt 22 works
- 2 Yonsei UniversitySouth Korea 21 works
- 3 Yale UniversityUnited States 21 works
- 4 Sağlık Bilimleri ÜniversitesiTürkiye 20 works
- 5 University College LondonUnited Kingdom 19 works
- 6 Harvard UniversityUnited States 18 works
- 7 All India Institute of Medical SciencesIndia 16 works
- 8 Universidade de São PauloBrazil 16 works
- 9 Emory UniversityUnited States 16 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 15 works
Who are the leading researchers in Botulinum Toxin and Related Neurological Disorders?
The most-cited researchers publishing on Botulinum Toxin and Related Neurological Disorders include Jasvinder A. Singh.
- 1 Jasvinder A. Singh United States 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Botulinum Toxin and Related Neurological Disorders research done?
The largest centres of Botulinum Toxin and Related Neurological Disorders research in 2022–2025 are Beijing (China), Seoul (South Korea), London (United Kingdom) and Paris (France).
Largest cities, 2022–2025
Where is the best place to study Botulinum Toxin and Related Neurological Disorders?
Among universities, judged by research, Yonsei University College of Dentistry, Yonsei University and Yale University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Yonsei University College of Dentistry?? | 67.3 | 37.1% | 110.5× | 9 | — |
| 2 | Yonsei UniversitySouth Korea | 52.8 | 24.8% | 4.2× | 21 | -12.6% |
| 3 | Yale UniversityUnited States | 49.9 | 9.7% | 3.1× | 21 | +383.3% |
| 4 | Harvard UniversityUnited States | 48.8 | 24.5% | 2.2× | 18 | +17.7% |
| 5 | Poznan University of Medical SciencesPoland | 48.6 | 18.0% | 7.5× | 8 | +188.5% |
| 6 | Sechenov UniversityRussia | 47.6 | 2.0% | 7.1× | 15 | +219.1% |
| 7 | Cairo UniversityEgypt | 47.0 | 4.3% | 4.2× | 22 | +152.4% |
| 8 | University College LondonUnited Kingdom | 45.0 | 18.2% | 2.0× | 19 | +28.9% |
| 9 | Sağlık Bilimleri ÜniversitesiTürkiye | 40.3 | 2.8% | 5.2× | 20 | — |
| 10 | University of Missouri–Kansas CityUnited States | 40.2 | 1.4% | 11.8× | 11 | +70.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Botulinum Toxin and Related Neurological Disorders research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Botulinum Toxin and Related Neurological Disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.